At the time of writing, CVS Health Corp [CVS] stock is trading at $55.77, down -0.50%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CVS shares have gain 3.22% over the last week, with a monthly amount drifted -4.13%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
CVS Health Corp [NYSE: CVS] stock has seen the most recent analyst activity on November 18, 2024, when Wells Fargo upgraded its rating to a Overweight and also boosted its price target to $66 from $60. Previously, Barclays upgraded its rating to Overweight on October 10, 2024, and elevated its price target to $82. On October 04, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $85 on the stock. Robert W. Baird started tracking the stock assigning a Neutral rating and suggested a price target of $61 on May 30, 2024. TD Cowen downgraded its rating to a Hold and reduced its price target to $59 on May 07, 2024. UBS downgraded its rating to Neutral for this stock on May 02, 2024, and downed its price target to $60. In a note dated May 01, 2024, Leerink Partners downgraded an Market Perform rating on this stock and revised its target price from $87 to $60.
For the past year, the stock price of CVS Health Corp fluctuated between $52.71 and $83.25. Currently, Wall Street analysts expect the stock to reach $98.5 within the next 12 months. CVS Health Corp [NYSE: CVS] shares were valued at $55.77 at the most recent close of the market. An investor can expect a potential return of 76.62% based on the average CVS price forecast.
Analyzing the CVS fundamentals
According to CVS Health Corp [NYSE:CVS], the company’s sales were 369.15B for trailing twelve months, which represents an 6.12% jump. Gross Profit Margin for this corporation currently stands at 0.14% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.07 and Total Capital is 0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.87.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 55.13 points at the first support level, and at 54.49 for the second support level. However, for the 1st resistance point, the stock is sitting at 56.56, and for the 2nd resistance point, it is at 57.35.
Ratios To Look Out For
It is important to note that CVS Health Corp [NYSE:CVS] has a current ratio of 0.80. In addition, the Quick Ratio stands at 0.59 and the Cash Ratio stands at 0.08. Considering the valuation of this stock, the price to sales ratio is 0.19, the price to book ratio is 0.94 and price to earnings (TTM) ratio is 14.17.
Transactions by insiders
Recent insider trading involved LUDWIG EDWARD J, Director, that happened on May 02 ’24 when 1000.0 shares were purchased. Director, Mahoney Michael F completed a deal on May 02 ’24 to buy 9181.0 shares. Meanwhile, EVP and Pres-Pharm, Consumer W Shah Prem S sold 29473.0 shares on Feb 16 ’24.
